|For adults ≥40 years with low fracture risk, we strongly recommend against OP medications due to known risk of harms and no evidence of benefit.|Very low|4.4a–4.13a|91–101|
|Adults receiving high-dose GC (initial dose≥30 mg/day for &gt;30 days or cumulative dose ≥5 g in 1 year) We conditionally recommend treating with PTH/PTHrP over anti-resorptives.|Low|6.1b–6.19a|120–141|
|Oral BP are strongly recommended over no treatment.|Low|6.1b–6.19a|120–141|